Article: Genzyme Launches Automated HDL Cholesterol Test

CAMBRIDGE, Mass., Oct. 17 /PRNewswire/ -- The diagnostic products unit of Genzyme Corp.'s General Division (Nasdaq: GENZ) announced today that it has begun marketing its N-geneous(TM) HDL cholesterol test in the United States.

The product launch follows clearance to market the test by the U.S. Food and Drug Administration's Center for Devices and Radiological Health.

The new test, which is being distributed by Genzyme under a worldwide agreement with the manufacturer of the test, Daiichi Pure Chemicals Co., Ltd., of Tokyo, measures how much high-density lipoprotein cholesterol is present in a patient's serum. It is simpler than other HDL ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!